Genre Early AccessReleased Oct 5, 2024

The Killing Antidote

Developed and published by MetalStar Studio
$29.99
Estimated lifetime revenue
$3.05M
Gross, before Steam's cut
Net revenue
$2.14M
After Steam's 30% cut
Units sold
160.8K
≈ 20 sales per review
Confidence
Medium
Based on 8,057 reviews
How we estimate →
Reviews
8,057
Very Positive87% positive
Playing now
198
3-day peak 198 · low 135
New reviews, last 3 days
+16
≈ 5 a day since Nov 12

History

Nov 12 – Nov 15

8.1K8.1K8.0K8.0K
Nov 12Nov 13Nov 15

Total Steam reviews. The slope is the signal: a steady climb long after launch means the game is still selling.

How it compares

Early Access →

Against the 140 most-reviewed Early Access games on Steam

Outearns 34% of them — below the group's median.

Median
$4.90M
26,277 reviews
Top 10% start at
$44.68M
This game
$3.05M
Fewest reviews of the group

The group is the games with the most reviews under this tag, not every release, so it leans toward games that sold — a percentile here is a harder test than the same percentile across the whole store would be.

About

This is a TPS game. Shooting, fighting, dress-up, puzzle solving, and more. In the future, a special germ causes humans to be constantly infected and mutated. The protagonist, Jodi, is a brave journalist who goes on her way to find the legendary antidote and is in danger.

Developer
MetalStar Studio
Publisher
MetalStar Studio
Genre
Early Access
Released
Oct 5, 2024
Steam app ID
2254890
Data updated
Nov 15, 2026
Estimates, not reported sales. No developer-published figures are on file for this game. See the methodology for how the numbers are built.